CryoLife Aims To Grab Share From Big Artificial Valve Players With On-X Buy
This article was originally published in Clinica
CryoLife is expanding its cardiac surgery portfolio, which has traditionally focused on tissue-based implants, to include artificial heart valves, after agreeing to acquire On-X Life Technologies in a $130m cash-and-stock deal.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.